| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000485438 | GALNT2-202 | 4030 | - | - | - (aa) | - | - |
| ENST00000488903 | GALNT2-203 | 593 | NR_120373 | - | - (aa) | - | - |
| ENST00000492568 | GALNT2-204 | 2766 | - | - | - (aa) | - | - |
| ENST00000494106 | GALNT2-205 | 692 | - | - | - (aa) | - | - |
| ENST00000366672 | GALNT2-201 | 4454 | XM_017000963 | ENSP00000355632 | 571 (aa) | XP_016856452 | Q10471 |
| ensgID | Trait | pValue | Pubmed ID |
|---|---|---|---|
| ENSG00000143641 | Cholesterol, HDL | 4.929e-006 | 19060910 |
| ENSG00000143641 | Cholesterol, HDL | 3.858e-005 | 19060910 |
| ENSG00000143641 | Cholesterol, HDL | 2.859e-006 | 19060910 |
| ENSG00000143641 | Peroxidases | 3E-6 | 23620142 |
| ENSG00000143641 | Schizophrenia | 8E-7 | 26198764 |
| ENSG00000143641 | Cholesterol, HDL | 4E-8 | 19060906 |
| ENSG00000143641 | Cholesterol, HDL | 4E-41 | 24097068 |
| ENSG00000143641 | Triglycerides | 2E-14 | 20686565 |
| ENSG00000143641 | Cholesterol, HDL | 3E-14 | 18193043 |
| ENSG00000143641 | Alzheimer Disease | 2E-6 | 25188341 |
| ENSG00000143641 | Dementia | 2E-6 | 25188341 |
| ENSG00000143641 | Fibrinogen | 8E-7 | 28107422 |
| ENSG00000143641 | Fibrinogen | 1E-8 | 28107422 |
| ENSG00000143641 | Lipoproteins | 2E-9 | 27005778 |
| ENSG00000143641 | Metabolism | 2E-9 | 27005778 |
| ENSG00000143641 | Alzheimer Disease | 4E-6 | 25188341 |
| ENSG00000143641 | Dementia | 4E-6 | 25188341 |
| ENSG00000143641 | Cholesterol, HDL | 1E-16 | 25961943 |
| ENSG00000143641 | Blood Proteins | 8E-6 | 23303382 |
| ENSG00000143641 | Cholesterol, HDL | 4E-21 | 20686565 |
| ENSG00000143641 | Triglycerides | 7E-31 | 24097068 |
| ENSG00000143641 | Cholesterol, HDL | 2E-13 | 18193044 |
| ENSG00000143641 | Triglycerides | 7E-15 | 18193044 |
| ENSG00000143641 | Triglycerides | 8E-7 | 18193043 |
| ENSG00000143641 | Metabolic Syndrome X | 4E-8 | 22399527 |
| ENSG00000143641 | Vascular Calcification | 1E-9 | 22916037 |
| ENSG00000143641 | Cholesterol, HDL | 4E-9 | 20864672 |
| ENSG00000143641 | Triglycerides | 5E-16 | 25961943 |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000143641 | rs7549029 | 1 | 230117659 | A | Blood protein levels | 29875488 | [0.13-0.25] unit increase | 0.19 | EFO_0007937 |
| ENSG00000143641 | rs16850871 | 1 | 230083723 | ? | Circulating odd-numbered chain saturated fatty acid levels (C23:0) | 29738550 | [0.01-0.022] unit decrease | 0.0164 | EFO_0005110 |
| ENSG00000143641 | rs7513659 | 1 | 230090639 | ? | Circulating odd-numbered chain saturated fatty acid levels (C23:0) | 29738550 | [0.01-0.022] unit increase | 0.0164 | EFO_0005110 |
| ENSG00000143641 | rs10864728 | 1 | 230169168 | G | Blood protein levels | 29875488 | [0.13-0.25] unit increase | 0.19 | EFO_0007937 |
| ENSG00000143641 | rs17315646 | 1 | 230159560 | G | Blood protein levels | 29875488 | [0.23-0.31] unit decrease | 0.27 | EFO_0007937 |
| ENSG00000143641 | rs590820 | 1 | 230173873 | G | Metabolite levels (lipoprotein measures) | 27005778 | [0.04-0.08] unit decrease | 0.06 | EFO_0004732|EFO_0005664 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | HDL cholesterol | 24097068 | [NR] unit decrease | 0.048 | EFO_0004612 |
| ENSG00000143641 | rs12040273 | 1 | 230063651 | ? | Carotid intima media thickness | 26343869 | EFO_0007117 | ||
| ENSG00000143641 | rs2144300 | 1 | 230159169 | T | HDL cholesterol | 18193043 | [NR] mg/dl increase | 1.11 | EFO_0004612 |
| ENSG00000143641 | rs4846923 | 1 | 230171476 | G | HDL cholesterol | 25961943 | [0.041-0.069] s.d. increase | 0.055 | EFO_0004612 |
| ENSG00000143641 | rs10864728 | 1 | 230169168 | A | Triglycerides | 25961943 | [0.04-0.064] s.d. increase | 0.052 | EFO_0004530 |
| ENSG00000143641 | rs11807834 | 1 | 230136877 | A | Schizophrenia | 26198764 | [NR] | 1.06 | EFO_0000692 |
| ENSG00000143641 | rs3761944 | 1 | 230253243 | C | Hematology traits | 23303382 | [0.0082-0.0238] unit increase | 0.016 | EFO_0005128 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | C | Circulating myeloperoxidase levels (serum) | 23620142 | [0.030-0.070] unit decrease | 0.05 | EFO_0005243 |
| ENSG00000143641 | rs10127775 | 1 | 230160042 | ? | Metabolite levels | 22916037 | EFO_0004723 | ||
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | Triglycerides | 24097068 | [NR] mg/dL increase | 0.04 | EFO_0004530 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | HDL cholesterol | 19060906 | [0.01-0.09] s.d. decrease | 0.05 | EFO_0004612 |
| ENSG00000143641 | rs10127775 | 1 | 230160042 | A | Blood protein levels | 28240269 | [0.24-0.41] unit increase | 0.3248 | EFO_0008113 |
| ENSG00000143641 | rs6541297 | 1 | 230147759 | A | Coronary artery disease | 29212778 | [0.019-0.051] unit decrease | 0.035 | EFO_0000378 |
| ENSG00000143641 | rs2281719 | 1 | 230161913 | T | Coronary artery disease | 29212778 | [0.018-0.04] unit decrease | 0.0289 | EFO_0000378 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | ? | Triglyceride levels | 29403010 | [0.019-0.041] unit decrease novel | 0.02985 | EFO_0004530 |
| ENSG00000143641 | rs7022 | 1 | 230281918 | G | Blood protein levels | 29875488 | [0.14-0.26] unit increase | 0.2 | EFO_0007937 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | ? | High density lipoprotein cholesterol levels | 29403010 | [0.024-0.05] unit increase novel | 0.03663 | EFO_0004612 |
| ENSG00000143641 | rs11122449 | 1 | 230164735 | T | Red cell distribution width | 27863252 | [0.029-0.045] unit increase | 0.03728932 | EFO_0005192 |
| ENSG00000143641 | rs4631704 | 1 | 230157783 | T | Platelet count | 27863252 | [0.016-0.031] unit increase | 0.02382391 | EFO_0004309 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | HDL cholesterol | 20686565 | [0.47-0.75] mg/dL decrease | 0.61 | EFO_0004612 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | Triglycerides | 20686565 | [2.02-3.5] mg/dL increase | 2.76 | EFO_0004530 |
| ENSG00000143641 | rs10489615 | 1 | 230169242 | G | HDL cholesterol | 20864672 | [0.01-0.03] unit increase | 0.02 | EFO_0004612 |
| ENSG00000143641 | rs4846922 | 1 | 230171436 | T | Metabolic syndrome | 22399527 | [NR] mmol/l decrease | 0.08 | EFO_0000195 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | HDL cholesterol | 18193044 | [0.05-0.09] unit decrease | 0.07 | EFO_0004612 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | Triglycerides | 18193044 | [0.06-0.10] unit increase | 0.08 | EFO_0004530 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | C | Triglycerides | 18193043 | [NR] mg/dl increase | 4.25 | EFO_0004530 |
| ENSG00000143641 | rs10489615 | 1 | 230169242 | ? | Fibrinogen levels | 28107422 | unit increase | 0.0052 | EFO_0004623 |
| ENSG00000143641 | rs10864726 | 1 | 230160406 | ? | Fibrinogen levels | 28107422 | unit increase | 0.0059 | EFO_0004623 |
| ENSG00000143641 | rs4846835 | 1 | 230145409 | A | Dementia and core Alzheimer's disease neuropathologic changes | 25188341 | [0.23-0.56] unit decrease | 0.3966 | HP_0000726|EFO_0006801 |
| ENSG00000143641 | rs4846835 | 1 | 230145409 | A | Dementia and core Alzheimer's disease neuropathologic changes | 25188341 | [0.26-0.66] unit decrease | 0.4595 | HP_0000726|EFO_0006801 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | T | HDL cholesterol levels | 28334899 | [0.036-0.076] unit increase | 0.056 | EFO_0004612 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | A | HDL cholesterol levels | 28334899 | [0.041-0.055] unit increase (EA Beta values) | 0.0479 | EFO_0004612 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | A | Triglyceride levels | 28334899 | [0.033-0.047] unit decrease (EA Beta values) | 0.0401 | EFO_0004530 |
| ENSG00000143641 | rs1546954 | 1 | 230168102 | G | Red cell distribution width | 28957414 | [0.022-0.038] unit increase | 0.0300215 | EFO_0005192 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | C | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.043 | EFO_0004612 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | C | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.043 | EFO_0004612 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.042 | EFO_0004612 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.041 | EFO_0004612 |
| ENSG00000143641 | rs10864728 | 1 | 230169168 | A | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.043 | EFO_0004612 |
| ENSG00000143641 | rs10864728 | 1 | 230169168 | A | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.04 | EFO_0004612 |
| ENSG00000143641 | rs1321257 | 1 | 230169566 | G | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.043 | EFO_0004612 |
| ENSG00000143641 | rs1321257 | 1 | 230169566 | G | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.04 | EFO_0004612 |
| ENSG00000143641 | rs4846923 | 1 | 230171476 | T | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.048 | EFO_0004612 |
| ENSG00000143641 | rs4846923 | 1 | 230171476 | T | High density lipoprotein cholesterol levels | 29507422 | unit decrease | 0.044 | EFO_0004612 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | C | Triglycerides | 29507422 | unit increase | 0.036 | EFO_0004530 |
| ENSG00000143641 | rs2144300 | 1 | 230159169 | C | Triglycerides | 29507422 | unit increase | 0.036 | EFO_0004530 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | Triglycerides | 29507422 | unit increase | 0.036 | EFO_0004530 |
| ENSG00000143641 | rs4846914 | 1 | 230159944 | G | Triglycerides | 29507422 | unit increase | 0.036 | EFO_0004530 |
| ENSG00000143641 | rs10864728 | 1 | 230169168 | A | Triglycerides | 29507422 | unit increase | 0.038 | EFO_0004530 |
| ENSG00000143641 | rs10864728 | 1 | 230169168 | A | Triglycerides | 29507422 | unit increase | 0.036 | EFO_0004530 |
| ENSG00000143641 | rs1321257 | 1 | 230169566 | G | Triglycerides | 29507422 | unit increase | 0.038 | EFO_0004530 |
| ENSG00000143641 | rs1321257 | 1 | 230169566 | G | Triglycerides | 29507422 | unit increase | 0.036 | EFO_0004530 |
| ENSG00000143641 | rs4846923 | 1 | 230171476 | T | Triglycerides | 29507422 | unit increase | 0.043 | EFO_0004530 |
| ENSG00000143641 | rs4846923 | 1 | 230171476 | T | Triglycerides | 29507422 | unit increase | 0.039 | EFO_0004530 |
| ENSG00000143641 | rs4846913 | 1 | 230158968 | ? | Red cell distribution width | 30595370 | EFO_0005192 | ||
| ENSG00000143641 | rs1043897 | 1 | 230280653 | ? | Red cell distribution width | 30595370 | EFO_0005192 | ||
| ENSG00000143641 | rs6703306 | 1 | 230216083 | G | Postburn scar pliability | 30595539 | [0.49-1.18] unit increase | 0.8324 | EFO_0007747 |
| ENSG00000143641 | rs10746509 | 1 | 230101535 | T | Neuroticism | 30643256 | [0.0059-0.0118] unit increase | 0.008847726 | EFO_0007660 |
| ENSG00000143641 | rs10746509 | 1 | 230101535 | T | Depressive symptoms | 30643256 | [0.0037-0.0075] unit increase | 0.005638635 | EFO_0007006 |
| ENSG00000143641 | rs3811489 | 1 | 230103512 | ? | Neuroticism | 30595370 | EFO_0007660 | ||
| ENSG00000143641 | rs10746509 | 1 | 230101535 | T | Well-being spectrum (multivariate analysis) | 30643256 | [0.0036-0.0073] unit increase | 0.005454711 | EFO_0007869 |
| ENSG00000143641 | rs10864726 | 1 | 230160406 | T | HDL cholesterol x physical activity interaction (2df test) | 30670697 | EFO_0007805|EFO_0003940 |

| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0000139 | Golgi membrane | - | TAS | Component |
| GO:0002378 | immunoglobulin biosynthetic process | 12438318. | IDA | Process |
| GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity | 9295285.12438318.16434399.18562306.19460755. | IDA | Function |
| GO:0005515 | protein binding | 21699783.25416956. | IPI | Function |
| GO:0005576 | extracellular region | - | IEA | Component |
| GO:0005789 | endoplasmic reticulum membrane | - | TAS | Component |
| GO:0005794 | Golgi apparatus | 21873635. | IBA | Component |
| GO:0005794 | Golgi apparatus | 9852147. | IDA | Component |
| GO:0005794 | Golgi apparatus | 12506059. | IDA | Component |
| GO:0005795 | Golgi stack | 9852147. | IDA | Component |
| GO:0006493 | protein O-linked glycosylation | 16434399.19460755. | IDA | Process |
| GO:0016020 | membrane | 19946888. | HDA | Component |
| GO:0016266 | O-glycan processing | 18562306. | IDA | Process |
| GO:0016266 | O-glycan processing | - | TAS | Process |
| GO:0018242 | protein O-linked glycosylation via serine | 9295285.12438318. | IDA | Process |
| GO:0018243 | protein O-linked glycosylation via threonine | 9295285.12438318.18562306. | IDA | Process |
| GO:0030145 | manganese ion binding | 9295285.16434399. | IDA | Function |
| GO:0030173 | integral component of Golgi membrane | 9852147. | NAS | Component |
| GO:0030246 | carbohydrate binding | - | IEA | Function |
| GO:0032580 | Golgi cisterna membrane | - | IEA | Component |
| GO:0048471 | perinuclear region of cytoplasm | 12506059. | IDA | Component |